Unlocking the potential of continuous glucose monitoring: a new guideline supports the development of continuous glucose monitoring devices.

Continuous glucose monitoring (CGM) is a new technology that allows patients to measure glucose levels continuously over several days. It has several advantages over traditional glucose meters in that it does not involve repeated finger sticks and can measure trends and track changes in glucose levels over time. The Clinical and Laboratory Standards Institute, working with the Diabetes Technology Society, published Performance Metrics for Continuous Interstitial Glucose Monitoring; Approved Guideline, which provides recommendations for methods for determining analytical and clinical metrics of CGMs. The document provides guidance on how CGM data should be presented, compared between devices, and compared between measurement technologies. The document serves as a roadmap for the testing of CGM devices and will ultimately advance the potential of this exciting technology. Performance Metrics for Continuous Interstitial Glucose Monitoring; Approved Guideline represents the consensus view on preparing and presenting CGM data.

New guideline supports the development and evaluation of continuous interstitial glucose monitoring devices.

For the millions of patients who are managing diabetes, daily self-monitoring of blood glucose is a fact of life. However, the cost and inconvenience of self-monitoring have led to noncompliance by many patients.Continuous interstitial glucose monitoring (CGM) has emerged as a promising and welcome alternative to traditional glucose monitoring, which requires the patient to endure repeated finger sticks. The Clinical and Laboratory Standards Institute (CLSI) (Wayne, PA) has been working cooperatively with the Diabetes Technology Society on the development of a consensus guideline for CGM. CLSI has recently released document POCT5-P-Performance Metrics for Continuous Interstitial Glucose Monitoring; Proposed Guideline. This document specifies requirements and recommendations for methods determining analytical and clinical metrics of CGM. This guideline will support and streamline the further development and evaluation of CGM devices.